Diagnostic Imaging Devices - Germany

Germany's Diagnostic Imaging Devices market market is expected to achieve a revenue of US$3.96bn by 2024.
This projection indicates a promising annual growth rate (CAGR 2024-2029) of 4.50%, leading to a market volume of US$4.93bn by 2029.
It is worth noting that, in a global context, the United States will generate the highest revenue with US$11.93bn in 2024.
Germany continues to lead the way in the Diagnostic Imaging Devices market, with its strong focus on innovation and high-quality healthcare.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Germany has been experiencing significant growth in recent years. Customer preferences for advanced imaging technologies, increasing incidence of chronic diseases, and favorable government initiatives have been driving this growth. Customer preferences in the German market are shifting towards more advanced imaging technologies such as magnetic resonance imaging (MRI) and computed tomography (CT). These technologies offer higher resolution images and better diagnostic capabilities, which are highly valued by both patients and healthcare professionals. In addition, there is a growing demand for portable and handheld imaging devices, as they provide convenience and flexibility in healthcare settings. The market is also being driven by the increasing incidence of chronic diseases in Germany. Chronic diseases such as cardiovascular diseases, cancer, and neurological disorders require frequent diagnostic imaging tests for accurate diagnosis and treatment. This has led to a higher demand for imaging devices in the country. Furthermore, the German government has implemented favorable initiatives to support the adoption of diagnostic imaging devices. For instance, the government has increased healthcare spending and introduced reimbursement policies to encourage the use of advanced imaging technologies. These initiatives have created a conducive environment for market growth and have attracted both domestic and international manufacturers to invest in the German market. In terms of local special circumstances, Germany has a well-established healthcare infrastructure and a high level of healthcare expenditure. The country has a large number of hospitals and diagnostic centers, which provide a strong customer base for imaging device manufacturers. Moreover, Germany has a highly skilled workforce and a strong research and development sector, which supports innovation and technological advancements in the market. Underlying macroeconomic factors such as a stable economy and a growing aging population also contribute to the growth of the diagnostic imaging devices market in Germany. The country's stable economy provides a favorable investment environment for manufacturers, while the aging population increases the demand for healthcare services and diagnostic imaging tests. In conclusion, the Diagnostic Imaging Devices market in Germany is experiencing significant growth due to customer preferences for advanced imaging technologies, increasing incidence of chronic diseases, favorable government initiatives, a well-established healthcare infrastructure, and underlying macroeconomic factors. These factors are expected to continue driving market growth in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.